Nitredon (Nitrazepam)

Nitrazepam is a benzodiazepine that modulates the GABA‑A receptor pathway, providing therapeutic effects in several central nervous system conditions.

• Insomnia: helps initiate and maintain sleep, reducing nighttime awakenings.
• Anxiety disorders: alleviates excessive worry and tension, promoting calmness.
• Preoperative sedation: provides calming and amnesic effects before surgical procedures.

• Nitrazepam binds to an allosteric site on the GABA‑A receptor complex, enhancing the affinity of the receptor for the inhibitory neurotransmitter gamma‑aminobutyric acid (GABA). This positive allosteric modulation increases chloride ion influx into neurons, hyperpolarising the cell membrane and reducing neuronal excitability, which produces sedative, anxiolytic, muscle‑relaxant and anticonvulsant effects. The enhanced GABAergic transmission leads to a generalized depressant effect on the central nervous system, accounting for its clinical utility in sleep induction and anxiety reduction.

Nitrazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Drowsiness: feeling of sleepiness during daytime.
• Dizziness: light‑headed sensation or loss of balance.
• Fatigue: reduced energy and increased tiredness.
• Impaired coordination: clumsiness or difficulty with fine motor tasks.
• Memory disturbances: short‑term recall problems.
• Headache: mild to moderate head pain.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing, especially with other depressants.
• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Paradoxical agitation: increased anxiety, aggression, or hostility.
• Dependence and withdrawal: physical or psychological reliance with abrupt discontinuation.
• Mood changes: depression or suicidal thoughts.
• Hepatic dysfunction: abnormal liver enzymes or jaundice.

When prescribing Nitrazepam, clinicians should consider several safety precautions to minimise risk.

• Assess medical history: evaluate for respiratory disorders, hepatic impairment, or glaucoma.
• Avoid abrupt discontinuation: taper dose gradually to prevent withdrawal symptoms.
• Use caution with CNS depressants: limit concurrent alcohol, opioids, or other sedatives.
• Monitor elderly patients: increased sensitivity may lead to falls or confusion.
• Pregnancy and lactation: prescribe only if benefits outweigh potential risks.
• Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Nitrazepam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Opioids: combined use may cause profound respiratory depression.
• Barbiturates: additive CNS depression can increase sedation and risk of overdose.
• Antifungal azoles (e.g., ketoconazole): may raise nitrazepam plasma levels, enhancing toxicity.
• Macrolide antibiotics (e.g., erythromycin): can inhibit metabolism, leading to accumulation.
• CNS depressants (e.g., antihistamines, muscle relaxants): heightened sedative effects.

Moderate Interactions (Monitor Closely)

• Antidepressants (SSRIs, SNRIs): may increase risk of serotonin syndrome or enhanced sedation.
• Anticonvulsants (phenytoin, carbamazepine): may reduce nitrazepam effectiveness.
• Herbal supplements (St. John’s wort): may induce metabolism, lowering drug concentration.
• Diuretics: may exacerbate electrolyte imbalances, affecting CNS stability.
• Caffeine: can counteract sedative effect, requiring dose adjustment.